Portal:Viruses

The Viruses Portal
Welcome!

The capsid of SV40, an icosahedral virus

Viruses are small infectious agents that can replicate only inside the living cells of an organism. Viruses infect all forms of life, including animals, plants, fungi, bacteria and archaea. They are found in almost every ecosystem on Earth and are the most abundant type of biological entity, with millions of different types, although only about 6,000 viruses have been described in detail. Some viruses cause disease in humans, and others are responsible for economically important diseases of livestock and crops.

Virus particles (known as virions) consist of genetic material, which can be either DNA or RNA, wrapped in a protein coat called the capsid; some viruses also have an outer lipid envelope. The capsid can take simple helical or icosahedral forms, or more complex structures. The average virus is about 1/100 the size of the average bacterium, and most are too small to be seen directly with an optical microscope.

The origins of viruses are unclear: some may have evolved from plasmids, others from bacteria. Viruses are sometimes considered to be a life form, because they carry genetic material, reproduce and evolve through natural selection. However they lack key characteristics (such as cell structure) that are generally considered necessary to count as life. Because they possess some but not all such qualities, viruses have been described as "organisms at the edge of life".

Selected disease

Child with a deformed right leg due to poliomyelitis

Polio, also called poliomyelitis or infantile paralysis, was one of the most feared childhood diseases of the 20th century. Poliovirus, the causative agent, only naturally infects humans and spreads via the faecal–oral route. Most infections cause no or minor symptoms. In around 1% of cases, the virus enters the central nervous system, causing aseptic meningitis. There it can preferentially infect and destroy motor neurons, leading in 0.1–0.5% of cases to muscle weakness and acute flaccid paralysis. Spinal polio accounts for nearly 80% of paralytic cases, with asymmetric paralysis of the legs being typical; in a quarter of these cases permanent severe disability results. Bulbar involvement is rare, but in severe cases the virus can prevent breathing by affecting the phrenic nerve, so that patients require mechanical ventilation with an iron lung or similar device.

Depictions in ancient art show that the disease has existed for thousands of years. The virus was an endemic pathogen until the 1880s, when major epidemics began to occur in Europe and later the United States. Polio vaccines were developed in the 1950s and a global eradication campaign started in 1988. The annual incidence of wild-type disease fell from many hundreds of thousands to 22 in 2017, but has since resurged to a few hundreds.

Selected image

False-coloured transmission electron micrograph of SARS-CoV-2 virions

False-coloured transmission electron micrograph of severe acute respiratory syndrome coronavirus 2, a novel coronavirus, showing the spikes (blue) forming a crown that give this group of RNA viruses their name. The spike protein interacts with the cellular receptor for the virus, angiotensin-converting enzyme 2.

Credit: National Institute of Allergy and Infectious Diseases (13 February 2020)

In the news

Map showing the prevalence of SARS-CoV-2 cases; black: highest prevalence; dark red to pink: decreasing prevalence; grey: no recorded cases or no data
Map showing the prevalence of SARS-CoV-2 cases; black: highest prevalence; dark red to pink: decreasing prevalence; grey: no recorded cases or no data

26 February: In the ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more than 110 million confirmed cases, including 2.5 million deaths, have been documented globally since the outbreak began in December 2019. WHO

18 February: Seven asymptomatic cases of avian influenza A subtype H5N8, the first documented H5N8 cases in humans, are reported in Astrakhan Oblast, Russia, after more than 100,0000 hens died on a poultry farm in December. WHO

14 February: Seven cases of Ebola virus disease are reported in Gouécké, south-east Guinea. WHO

7 February: A case of Ebola virus disease is detected in North Kivu Province of the Democratic Republic of the Congo. WHO

4 February: An outbreak of Rift Valley fever is ongoing in Kenya, with 32 human cases, including 11 deaths, since the outbreak started in November. WHO

21 November: The US Food and Drug Administration (FDA) gives emergency-use authorisation to casirivimab/imdevimab, a combination monoclonal antibody (mAb) therapy for non-hospitalised people twelve years and over with mild-to-moderate COVID-19, after granting emergency-use authorisation to the single mAb bamlanivimab earlier in the month. FDA 1, 2

18 November: The outbreak of Ebola virus disease in Équateur Province, Democratic Republic of the Congo, which started in June, has been declared over; a total of 130 cases were recorded, with 55 deaths. UN

Selected article

Ribbon diagram of HIV reverse transcriptase

Reverse transcriptase is an enzyme that generates complementary DNA from an RNA template, in contrast to the usual information flow from DNA to RNA. It was discovered in Rous sarcoma virus and murine leukaemia virus, two retroviruses, by Howard Temin and David Baltimore, working independently in 1970, for which the two shared the Nobel Prize in Physiology or Medicine.

Reverse transcription is essential for the replication of retroviruses, allowing them to integrate into the host genome as a provirus. The enzyme is a target for reverse-transcriptase inhibitors, a major class of anti-HIV drugs. Reverse transcription is also used by Hepadnaviridae and Caulimoviridae, DNA viruses that replicate via an RNA intermediate, such as hepatitis B. The process is important in the movement of retrotransposons, a type of mobile genetic element, and in the extension of chromosome ends in eukaryotic genomes. The enzyme is widely used in the laboratory for molecular cloning, RNA sequencing, polymerase chain reaction and genome analysis.

Selected outbreak

Villagers in Yambuku, Zaire, being examined by staff from the US CDC

The 1976 Zaire Ebola virus outbreak was one of the first two recorded outbreaks of the disease. The causative agent was identified as a novel virus, named for the region's Ebola River. The first identified case, in August, worked in the school in Yambuku, a small rural village in Mongala District, north Zaire. He had been treated for suspected malaria at the Yambuku Mission Hospital, which is now thought to have spread the virus by giving vitamin injections with inadequately sterilised needles, particularly to women attending prenatal clinics. Unsafe burial practices also spread the virus.

The outbreak was contained by quarantining local villages, sterilising medical equipment and providing protective clothing to medical personnel, and was over by early November. A total of 318 cases was recorded, of whom 280 died, an 88% case fatality rate. An earlier outbreak in June–November in Nzara, Sudan, was initially thought to be linked, but was shown to have been caused by a different species of Ebola virus.

Selected quotation

Recommended articles

Viruses & Subviral agents: bat virome • elephant endotheliotropic herpesvirus • HIV • introduction to virusesFeatured article • Playa de Oro virus • poliovirus • prion • rotavirusFeatured article • virusFeatured article

Diseases: colony collapse disorder • common cold • croup • dengue feverFeatured article • gastroenteritis • Guillain–Barré syndrome • hepatitis B • hepatitis C • hepatitis E • herpes simplex • HIV/AIDS • influenzaFeatured article • meningitisFeatured article • myxomatosis • polioFeatured article • pneumonia • shingles • smallpox

Epidemiology & Interventions: 2007 Bernard Matthews H5N1 outbreak • Coalition for Epidemic Preparedness Innovations • Disease X • 2009 flu pandemic • HIV/AIDS in Malawi • polio vaccine • Spanish flu • West African Ebola virus epidemic

Virus–Host interactions: antibody • host • immune systemFeatured article • parasitism • RNA interferenceFeatured article

Methodology: metagenomics

Social & Media: And the Band Played On • Contagion • "Flu Season" • Frank's CockFeatured article • Race Against Time: Searching for Hope in AIDS-Ravaged AfricaFeatured article • social history of virusesFeatured article • "Steve Burdick" • "The Time Is Now" • "What Lies Below"

People: Brownie Mary • Macfarlane BurnetFeatured article • Bobbi Campbell • Aniru Conteh • people with hepatitis CFeatured article • HIV-positive peopleFeatured article • Bette Korber • Henrietta Lacks • Linda Laubenstein • Barbara McClintockFeatured article • poliomyelitis survivorsFeatured article • Joseph Sonnabend • Eli Todd • Ryan WhiteFeatured article

Selected virus

Structure of adeno-associated virus serotype 2

Adeno-associated viruses (AAVs) are two small DNA viruses in the Dependoparvovirus genus of the Parvoviridae family. They cannot complete their lytic replication cycle without a helper virus, which include adenoviruses, herpesviruses and vaccinia. In the absence of the helper, AAVs can integrate into the host genome at a specific site on human chromosome 19, or persist as an episome. The 20 nm icosahedral capsid lacks an envelope, and contains a single-stranded DNA genome of around 4.7 kb. AAVs infect humans and some other primates without causing disease. They generate only a mild immune response, including neutralising antibodies. The best-studied of the 11 serotypes, AAV-2, infects nerve cells, liver cells, skeletal muscle and vascular smooth muscle, using heparan sulphate proteoglycan as its primary receptor.

Its low pathogenicity makes AAV an attractive basis for viral vectors for gene therapy. Alipogene tiparvovec to treat lipoprotein lipase deficiency was the first gene therapy to be licensed, but was later withdrawn. Promising results have been obtained in early clinical trials with AAV-based gene therapy in haemophilia, congestive heart failure, spinal muscular atrophy, Parkinson's disease and the rare eye disease Leber congenital amaurosis.

Did you know?

Scanning electron micrograph showing SARS-CoV-2 (yellow)

Selected biography

Thomas Flewett in 1984

Thomas Flewett (29 June 1922 – 12 December 2006) was a British–Irish virologist and an authority on electron microscopy of viruses, best known for his role in the discovery of rotaviruses. After Ruth Bishop and others discovered viruses associated with diarrhoea, Flewett showed that they could be visualised by electron microscopy directly in faeces. He dubbed them "rotaviruses" for their wheel-shaped appearance. His group described the different rotavirus serotypes, and did extensive research on the rotavirus varieties infecting many animals.

Flewett established one of the first English virus laboratories in Birmingham in 1956. In addition to his rotavirus work, he discovered the cause of hand, foot and mouth disease, identified two new species of adenovirus, and co-discovered human torovirus and picobirnaviruses. His other research included influenza, coxsackie A, coxsackie B and hepatitis B viruses.

In this month

Painting depicting Jenner inoculating Phipps by Ernest Board (c. 1910)

May 1955: First issue of Virology; first English-language journal dedicated to virology

4 May 1984: HTLV-III, later HIV, identified as the cause of AIDS by Robert Gallo and coworkers

5 May 1939: First electron micrographs of tobacco mosaic virus taken by Helmut Ruska and coworkers

5 May 1983: Structure of influenza neuraminidase solved by Jose Varghese, Graeme Laver and Peter Colman

8 May 1980: WHO announced formally the global eradication of smallpox

11 May 1978: SV40 sequenced by Walter Fiers and coworkers

12 May 1972: Gene for bacteriophage MS2 coat protein is sequenced by Walter Fiers and coworkers, the first gene to be completely sequenced

13 May 2011: Boceprevir approved for the treatment of chronic hepatitis C virus (HCV) infection, the first direct-acting antiviral for HCV

14 May 1796: Edward Jenner inoculated James Phipps (pictured) with cowpox

15/16 May 1969: Death of Robert Rayford, the earliest confirmed case of AIDS outside Africa

18 May 1998: First World AIDS Vaccine Day

20 May 1983: Isolation of the retrovirus LAV, later HIV, by Luc Montagnier, Françoise Barré-Sinoussi and coworkers

23 May 2011: Telaprevir approved for the treatment of chronic HCV infection

25 May 2011: WHO declared rinderpest eradicated

31 May 1937: First results in humans from the 17D vaccine for yellow fever published by Max Theiler and Hugh H. Smith

Selected intervention

Ball-and-stick model of ribavirin

Ribavirin is a nucleoside analogue that mimics the nucleoside guanosine. It shows some activity against a broad range of DNA and RNA viruses, but is less effective against dengue fever, yellow fever and other flaviviruses. The drug was first synthesised in the early 1970s by Joseph T. Witkowski and Roland K. Robins. Ribavirin's main current use is against hepatitis C, in combination with pegylated interferon, nucleotide analogues and protease inhibitors. It has been used in the past in an aerosol formulation against respiratory syncytial virus-related diseases in children. Ribavirin has been used in combination as part of an experimental treatment for rabies. It is also the only available treatment for the viruses causing some viral haemorrhagic fevers, including Lassa fever, Crimean–Congo haemorrhagic fever and hantavirus disease, but is ineffective against the filovirus diseases, Ebola and Marburg. Clinical use is limited by the drug building up in red blood cells to cause haemolytic anaemia.

Subcategories

Topics

Things to do

WikiProjects & Portals

Associated Wikimedia

The following Wikimedia Foundation sister projects provide more on this subject:

Wikibooks
Books

Commons
Media

Wikinews 
News

Wikiquote 
Quotations

Wikisource 
Texts

Wikiversity
Learning resources

Wiktionary 
Definitions

Wikidata 
Database

Wikispecies 
Species